GFAP and neoplasm: In fact, according to our in vivo results, the GFAP/CD133+CD90+/CD44+ cells maybe the cell population responsible for EPN dissemination, leading to reduced patient survival due to the inherent chemoresistance of this tumor [17, 18, 23].